Log in to save to my catalogue

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid ho...

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid ho...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_909750441

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

About this item

Full title

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Publisher

England: Elsevier Ltd

Journal title

The lancet oncology, 2011-11, Vol.12 (12), p.1101-1108

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Postmenopausal women with hormone receptor-positive early breast cancer have persistent, long-term risk of breast-cancer recurrence and death. Therefore, trials assessing endocrine therapies for this patient population need extended follow-up. We present an update of efficacy outcomes in the Breast International Group (BIG) 1-98...

Alternative Titles

Full title

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_909750441

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_909750441

Other Identifiers

ISSN

1470-2045

E-ISSN

1474-5488

DOI

10.1016/S1470-2045(11)70270-4

How to access this item